Skip to main content
· 6/6/2014

City of Edinburgh Council as A v. Pfizer Inc

Citations

  • 754 F.3d 159
  • 2014 WL 2535383
  • 2014 U.S. App. LEXIS 10550

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that, because plaintiffs “failed to adequately plead a predicate section 10(b) violation, their section 20(a) claim must be dismissed”
  • holding that “[i]nterpretations of clinical trial data are considered opinions . . . only 25 actionable under the securities laws if they are not honestly believed and lack a reasonable basis.”
  • suggesting that a company's failure to accurately disclose clinical data may be actionable where it made affirmative false statements about a drug's safety
  • indicating that a company's failure to accurately disclose clinical trial data may be actionable, but suggesting no duty to disclose where there were no affirmative statements about its Phase 2 study results
  • holding at the motion to dismiss stage that the adjective “spectacular” was a 6 Case: 19-20298 Document: 00515532811 Page: 7 Date Filed: 08/19/2020 No. 19-20298 vague and general statement of optimism that was not misleading
  • explaining that the PSLRA imposes “heightened pleading standards” in securities fraud actions

Source: CourtListener parenthetical corpus (CC0).

Judges: Smith, Shwartz, Scirica

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.